Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | LSS | P48449 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25199783 | 0.91 | APP (0.39) | LTA4HAPPPTGS1PDE4ALMNA | |
| SCHEMBL23016833 | 0.89 | APP (0.38) | LTA4HAPPPTGS1PDE4ALMNA | |
| SCHEMBL6115089 | 0.89 | LTA4H (0.47) | LTA4HAPPPTGS1PDE4ALMNA | |
| SCHEMBL10985301 | 0.86 | LTA4H (0.40) | LTA4HAPPPTGS1PDE4ALMNA | |
| SCHEMBL13439937 | 0.86 | LTA4H (0.44) | LTA4HAPPPTGS1PDE4ALMNA | |
| SCHEMBL17058738 | 0.85 | APP (0.38) | LTA4HAPPPTGS1PDE4ALMNA | |
| SCHEMBL16063018 | 0.85 | APP (0.38) | LTA4HAPPPTGS1PDE4ALMNA | |
| SCHEMBL16063023 | 0.83 | APP (0.37) | LTA4HAPPPTGS1PDE4ALMNA | |
| SCHEMBL16063010 | 0.83 | APP (0.39) | LTA4HAPPPTGS1PDE4ALMNA | |
| SCHEMBL19708222 | 0.83 | LTA4H (0.44) | LTA4HAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150246988-A1 | METHOD FOR PRODUCING ZWITTERIONIC MONOMERS AND USE OF SAID MONOMERS | KARLSRUHER INSTITUT FUER TECHNOLOGIE (DE) | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246988-A1 | METHOD FOR PRODUCING ZWITTERIONIC MONOMERS AND USE OF SAID MONOMERS | AS3MT, ACMSD, CD14 | LTA4H 1340/4885APP 2673/4885PTGS1 1283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.